The University of Texas Health Science CenterHouston, Texas, United States
P88. Prospective evaluation of safety and patient satisfaction with apixaban versus low molecular weight heparin for extended prophylaxis after cancer surgery
Friday, March 6, 20263:26 PM - 3:33 PM MST
